GTCR
http://www.gtcr.com/GTCR is a private equity firm with $8 billion in equity and mezzanine capital under management. The firm focuses on the transaction processing, consumer products and services, healthcare, technology, and business services and outsourcing sectors. Since its inception, the firm has invested in more than one hundred companies and taken more than thirty companies public. GTCR is based in Chicago, IL and was founded in 1980.
-
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8
-
Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
-
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
-
SurModics (SRDX) issues Statement on FTC Challenge to Proposed Acquisition by Funds Affiliated with GTCR
-
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR
-
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results
-
Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
-
SurModics (SRDX) Tops Q3 EPS by 7c, suspends previous guidance
-
Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SRDX, ATRI on Behalf of Shareholders
-
SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Surmodics to GTCR
-
SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Surmodics to GTCR
-
Needham Downgrades SurModics (SRDX) to Hold
-
SurModics (SRDX) to be Acquired by GTCR for $43.00 Per Share in Cash, Equity Value of $627 Million
-
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
